25682-016 : Strensiq 40 mg/ml Subcutaneous Solution

Labeler: Alexion Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Strensiq
Dosage Form: Subcutaneous Solution
Application #: BLA125513
Rev. Date: 

NDC Package Codes:

  • 25682-016-12: 12 VIAL IN 1 CARTON (25682‑016‑12) > 2 ML IN 1 VIAL (25682‑016‑01)

Active Ingredients:

  • Asfotase Alfa

Dosage Strength:

  • 40 mg/mL

Pharmaceutical Classes:

  • Tissue-nonspecific Alkaline Phosphatase [EPC]
  • Alkaline Phosphatase [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 25682-010 Strensiq 18 mg/.45ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-013 Strensiq 28 mg/.7ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-019 Strensiq 80 mg/.8ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.


Scan the QR code below to easily reference this data in the future:

NDC 25682-016 QR Code

< Prev: 25682-013Next: 25682-019 >

Related Discussions:

Drug Interactions alfa and beta blockers
i take flomax and a beta blocker....one is a alfa blocker....i was told that they should not be taken together..thanks #... 4 replies
Generic Aranesp (darbepoetin alfa)
Cresp (Vials) is a low-cost version of long-acting anemia drug darbepoetin alfa (Aranesp). Crep Vials Cost USD 175$ for ... 1 reply
Monocef 200 Mg, Levoflox 500mg and Alfatam 0.4mg
we want full information about monocef 200mg, levoflox 500mg and aflatam 0.4mg. what for the medicines are? why to consu... 2 replies
Dosage Of Chromium Picolinate 500 Mcg Alfacalcidol 0 5mcg Biotin 1 Mg N Acetyl L Cysteine 600
chromium picolinate 500 mcg+alfacalcidol 0.5mcg+biotin 1 mg+n-acetyl-l-cysteine 600 mg ## What has your doctor advised? ... 1 reply
darbepoetin alfa, nonesrd
reason prescribed, underlying conditions ## My doctor wants me to use this for kidney failure?... 1 reply
Methylcobalamine Alfacalcidol Combination Is Available In India
Is methylcobalamine in combination with alfacalcidol is available in India??...

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.